Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Cash from Financing Activities (2020 - 2025)

Historic Cash from Financing Activities for KORU Medical Systems (KRMD) over the last 10 years, with Q3 2025 value amounting to $396330.0.

  • KORU Medical Systems' Cash from Financing Activities rose 584.21% to $396330.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$172158.0, marking a year-over-year increase of 1847.5%. This contributed to the annual value of -$248533.0 for FY2024, which is 1355.44% down from last year.
  • KORU Medical Systems' Cash from Financing Activities amounted to $396330.0 in Q3 2025, which was up 584.21% from -$191964.0 recorded in Q2 2025.
  • KORU Medical Systems' 5-year Cash from Financing Activities high stood at $2.2 million for Q1 2021, and its period low was -$262226.0 during Q2 2022.
  • Over the past 5 years, KORU Medical Systems' median Cash from Financing Activities value was -$160808.0 (recorded in 2025), while the average stood at $134785.5.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first skyrocketed by 11942.48% in 2021, then tumbled by 3215412.05% in 2022.
  • Over the past 5 years, KORU Medical Systems' Cash from Financing Activities (Quarter) stood at -$133714.0 in 2021, then decreased by 8.89% to -$145603.0 in 2022, then decreased by 22.49% to -$178355.0 in 2023, then decreased by 20.95% to -$215716.0 in 2024, then soared by 283.73% to $396330.0 in 2025.
  • Its last three reported values are $396330.0 in Q3 2025, -$191964.0 for Q2 2025, and -$160808.0 during Q1 2025.